Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
In Millions, unless otherwise specified
Mar. 31, 2014
Mar. 31, 2013
Current assets:    
Cash and cash equivalents $ 167.5 $ 153.7
Restricted cash and cash equivalents 3.2 2.5
Restricted cash and cash equivalents - Asbestos 60.2 126.4
Restricted short-term investments - Asbestos 0.1 7.1
Accounts and other receivables, net of allowance for doubtful accounts of US$1.0 million and US$2.1 million as of 31 March 2014 and 31 March 2013, respectively 139.2 149.0
Inventories 190.7 172.1
Prepaid expenses and other current assets 21.9 19.2
Insurance receivable - Asbestos 28.0 22.2
Workers' compensation - Asbestos 4.3 0.9
Deferred income taxes 21.6 24.9
Deferred income taxes - Asbestos 16.5 18.6
Total current assets 653.2 696.6
Restricted cash and cash equivalents 1.8 2.5
Property, plant and equipment, net 711.2 658.9
Insurance receivable - Asbestos 198.1 209.4
Workers' compensation - Asbestos 47.6 60.7
Deferred income taxes 11.7 20.6
Deferred income taxes - Asbestos 455.2 434.1
Other assets 27.7 30.4
Total assets 2,106.5 2,113.2
Current liabilities:    
Accounts payable and accrued liabilities 142.0 103.7
Current portion of long-term debt - Asbestos 47.0  
Dividends payable 124.6  
Accrued payroll and employee benefits 56.7 44.0
Accrued product warranties 7.7 6.6
Income taxes payable 5.4 6.0
Asbestos liability 134.5 135.0
Workers' compensation - Asbestos 4.3 0.9
Other liabilities 15.0 26.7
Total current liabilities 537.2 322.9
Deferred income taxes 93.0 95.4
Accrued product warranties 23.7 20.5
Asbestos liability 1,571.7 1,558.7
Workers' compensation - Asbestos 47.6 60.7
Other liabilities 32.3 36.8
Total liabilities 2,305.5 2,095.0
Commitments and contingencies (Note 13)      
Shareholders' equity:    
Common stock, Euro 0.59 par value, 2.0 billion shares authorised; 445,033,502 shares issued at 31 March 2014 and 441,644,484 shares issued at 31 March 2013 230.6 227.3
Additional paid-in capital 139.7 101.1
Accumulated deficit (602.4) (357.6)
Accumulated other comprehensive income 33.1 47.4
Total shareholders' (deficit) equity (199.0) 18.2
Total liabilities and shareholders' (deficit) equity $ 2,106.5 $ 2,113.2